コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 llows brief periods of ischemia ("myocardial stunning").
2 ximately 50%) ("late preconditioning against stunning").
3 3 d later (late preconditioning [PC] against stunning).
4 urs later (late preconditioning [PC] against stunning).
5 ctive response (late preconditioning against stunning).
6 x microstructural patterns that are visually stunning.
7 annel blockers have been shown to ameliorate stunning.
8 lation to ischemic stress, which induced the stunning.
9 ed for hours or days because of postischemic stunning.
10 s diagnostic scan for any visual evidence of stunning.
11 n in a canine model of repetitive myocardial stunning.
12 oiodine ablation without concern for thyroid stunning.
13 ndicating the development of late PC against stunning.
14 use atherosclerotic disease or microvascular stunning.
15 ny delayed deleterious actions on myocardial stunning.
16 unknown whether it triggers late PC against stunning.
17 amine stress and a reduction in postischemic stunning.
18 his gene therapy protects against myocardial stunning.
19 ate (ISMN, 50 mg once daily) on postexercise stunning.
20 ndicating the development of late PC against stunning.
21 ther, suggesting the induction of myocardial stunning.
22 p IV, n = 6) failed to block late PC against stunning.
23 dicating a late PC effect against myocardial stunning.
24 m overload implicated in the pathogenesis of stunning.
25 the sixth reperfusion, indicating myocardial stunning.
26 utamine recovery, consistent with myocardial stunning.
27 myofilament proteolysis underlies myocardial stunning.
28 e of late preconditioning against myocardial stunning.
29 mined at baseline, during ischemia and after stunning.
30 of the first sequence, indicating myocardial stunning.
31 gineered human-transmissible H5N1 strain are stunning.
32 species, has been associated with myocardial stunning.
33 diagnostic (131)I, the phenomenon was called stunning.
34 -C during reperfusion may prolong myocardial stunning.
35 ion of blood flow, which is called metabolic stunning.
36 or swelling and failed to prevent myocardial stunning.
37 with no stunning, and group S, patients with stunning.
38 ared with postablation scans for evidence of stunning.
39 ion (group 3, n = 6), designed to produce no stunning.
40 th the protective effects of late PC against stunning.
41 olecular identification, and the results are stunning.
42 ardium but may not play a role in reversible stunning.
43 emic preconditioning (PC) against myocardial stunning.
44 ective effects of late PC against myocardial stunning.
45 SOD2) isoforms to protect against myocardial stunning.
46 xygen species (ROS) contribute to myocardial stunning.
47 and duration of postconversion left atrial "stunning."
48 confer marked protection against myocardial stunning 1-3 d later (late preconditioning [PC] against
49 e from the natural product itself that are a stunning 100-fold more active (IC50 values, 50-75 pM vs.
51 id not exacerbate the severity of myocardial stunning 24 hours later; therefore, the absence of late
52 he heart relatively resistant to myocardial "stunning" 24 hours later (late preconditioning [PC] agai
53 of trehalases in desiccated cell reveals the stunning ability of cells to retain enzymatic activity w
54 In the basic science arena, there have been stunning advancements that illustrate novel biological a
55 ther molecules that mediate taste has led to stunning advances in our understanding of the basic mech
58 0% for 90 minutes, and subsequent myocardial stunning after reperfusion in chronically instrumented c
62 pite such response dimorphism, we observed a stunning anatomical monomorphism of cortical penis and c
63 ts; p = 0.03) for patients predicted to have stunning and a marked decline in LVEF outside the infarc
64 , clinical exploitation of the powerful anti-stunning and anti-infarct actions of late PC has been el
65 ated TnI proteolysis can be dissociated from stunning and arises from elevations in preload rather th
66 similarly may be associated with myocardial stunning and cell necrosis associated with ischemia/repe
67 ardial infarction (MI) because of myocardial stunning and compensatory hyperkinesia in noninfarct-rel
69 hat relates to the time course of myocardial stunning and differs transmurally in relation to ischemi
71 ught to prospectively identify patients with stunning and hyperkinesia at hospital discharge on the b
73 before ischemia would enhance the degree of stunning and induce a sustained decrease in glucose upta
74 ne receptor agonist, in models of myocardial stunning and infarction in chronically instrumented cons
76 e effects of late PC against both myocardial stunning and myocardial infarction, indicating that COX-
77 e effects of late PC against both myocardial stunning and myocardial infarction, indicating that NF-k
80 mmalian models of both ischemia/reperfusion (stunning) and chronic pressure overload with hypertrophy
81 powerful protection against both reversible (stunning) and irreversible (infarction) injury during ac
82 tion 24 hours later against both reversible (stunning) and irreversible (infarction) ischemia/reperfu
83 result in reduced postoperative reversible (stunning) and irreversible myocardial injury, as assesse
84 rt failure, ischemia and reperfusion injury, stunning, and familial hypertrophic cardiac myopathies.
87 est remains normal, consistent with "chronic stunning," and contrasts with reduced flow and increased
88 lso prevented the contractile dysfunction of stunning; and (3) calpain I could similarly degrade TnI,
89 mia can have a negative effect on the heart: stunning; and on the other hand, they have a protective
92 nt cellular processes, leading to myocardial stunning, arrhythmias, and ultimately cell damage and de
93 S and MPT have been implicated in myocardial stunning associated with reperfusion in ischemic hearts,
94 ROS contribute to the genesis of myocardial stunning but, at the same time, trigger the development
96 thout catalase fails to alleviate myocardial stunning, but extracellular SOD (Ec-SOD) may be more eff
97 implicated in the pathogenesis of myocardial stunning, but the precise mechanism by which OFRs foster
98 fibrillation (AF) is associated with atrial stunning, but the short-term effect of a brief episode o
99 oronary occlusions induces severe myocardial stunning, but when the same sequence is repeated 24 hour
100 st the hypothesis that persistent myocardial stunning can lead to hibernating myocardium, 13 pigs wer
103 scope from the Sputnik era, they assembled a stunning collection of micrographs that illustrated how
104 Prior structural studies have revealed the stunning complexity of the purified rotor and C-ring ass
106 id left ventricular pacing and that regional stunning contributes to persistent global left ventricul
107 schemic LV dysfunction at 1 and 7 days after stunning correlates with the degree of enhanced regional
110 The former is often preferred to avoid "stunning"-defined as a reduction in uptake of the therap
111 their design, have allowed the creation of a stunning diversity of nucleic acid-based nanodevices.
112 rimary difficulties exist: Viruses exhibit a stunning diversity of strategies for evading the host im
115 dose of (131)I produces a visually apparent stunning effect 72 h before (131)I ablation therapy.
116 10 mCi) (131)I may be capable of producing a stunning effect on thyroid tissue that may interfere wit
117 APC and IPC exhibit anti-infarct and anti-stunning effects in the ovine heart, but these effects a
118 study, the anti-infarct effects and the anti-stunning effects of APC in contributing to enhanced post
121 this symbiosis has produced one of the most stunning examples of rapid adaptive radiation documented
123 obably with immune compromise following cold stunning (extended hypothermia), developed a disseminate
124 an immediate injurious role (as mediators of stunning) followed by a useful function (as mediators of
125 cted to a partial occlusion to produce acute stunning, followed by reperfusion through a critical ste
126 hough doxycycline did not improve myocardial stunning following coronary artery bypass graft surgery
129 echocardiography accurately differentiates 'stunning' from necrosis, delineates transmural extent of
130 duced late PC effect against both myocardial stunning (groups VII through X) and myocardial infarctio
132 tic (131)I were measured at 2 d, a time when stunning has been observed, and expressed as ratios of r
137 hemia-reperfusion-induced LV dysfunction or "stunning" have normal contractile function and normal [C
139 with single particle averaging, has produced stunning images of the intact bacterial flagellum, revea
141 nt time after ischemia eliminates myocardial stunning in conscious pigs during augmented carbohydrate
142 the mechanism of late PC against myocardial stunning in conscious rabbits involves a PKC-mediated si
143 he development of late PC against myocardial stunning in conscious rabbits, indicating that NO genera
147 ing the genes up-regulated during myocardial stunning, including those not previously described in th
148 development of late preconditioning against stunning, indicating that the production of reactive oxy
149 th chronic animal window models has provided stunning insight into tumor pathophysiology, including g
150 m salvaged by reperfusion." The mechanism of stunning involves generation of oxygen radicals as well
153 ilament proteins in situ during ischemia and stunning is evaluated, and it is concluded that C-termin
155 is repeated 24 hours later, the severity of stunning is markedly reduced (approximately 50%) ("late
157 ecovery of this postresuscitation myocardial stunning is seen by 48 h in this experimental model of v
158 esis that the development of late PC against stunning is triggered by increased generation of NO duri
160 h transient contractile dysfunction, termed "stunning." It is not clear whether this phenomenon is pr
166 dramatic subunit rearrangements, providing a stunning molecular explanation for the allosteric regula
167 ion followed by reperfusion to create either stunning (n=12) or transmural myocardial infarction (n=1
172 t to determine whether left atrial appendage stunning occurs in patients with atrial flutter and to c
176 These results support the hypothesis that "stunning" of thyroid tissues, often observable by 2 d, i
177 d by XO + P, mimic the effects of myocardial stunning on cardiac excitation-contraction coupling.
178 ecessary not only to trigger late PC against stunning on day 1 but also to mediate the protection on
179 idant therapy markedly attenuates myocardial stunning on day 1, indicating that ROS play an important
180 ntioxidant therapy in attenuating myocardial stunning on day 1, it has no effect on late precondition
181 a (group VI, n = 11) induced late PC against stunning on day 2 and the magnitude of this effect was e
182 r; therefore, the absence of late PC against stunning on day 2 in group II cannot be ascribed to a de
183 rmed on day 1 failed to precondition against stunning on day 2, but the same sequence performed on da
186 However, data did not show any effect of stunning on the efficacy of 131I therapy for differentia
187 y compared the effects of porcine myocardial stunning on the uptake of [18F]-fluorodeoxyglucose (FDG)
188 the 10th reperfusion, indicating myocardial "stunning." On days 2 and 3, however, the recovery of WTh
195 d to produce different degrees of myocardial stunning; or (c) a single episode of 2 minutes of occlus
197 The future challenge is how to minimize the stunning phenomenon and maximize the preconditioning phe
201 he role of the erbB2 gene in cancers and the stunning progress in developing targeted therapies for e
202 arch, we explore the gap between 25 years of stunning progress in fundamental neuroscience and the pe
204 he perfusion findings suggested that chronic stunning rather than hibernation is the principal cause
205 reduced L-type Ca2+ current contribute to a stunning reduction of intracellular Na+ concentration fo
206 felt to be sufficient to allow recovery from stunning, regional function was disproportionately low f
208 hus, late preconditioning against myocardial stunning requires > 6 hours to develop, lasts for at lea
210 ernation may represent persistent myocardial stunning resulting from repeated episodes of ischemia an
214 o decades of network science have discovered stunning similarities in the topological characteristics
218 ays and protects against both infarction and stunning, suggesting that it may have greater clinical r
219 development of late preconditioning against stunning supports a complex pathophysiological paradigm,
221 a unique metabolic adaptation in repetitive stunning that is different from that typically seen in c
223 protects against infarction but not against stunning, the late phase of PC lasts 3 to 4 days and pro
233 ere chronically instrumented, and persistent stunning was induced regionally by 6 repetitive episodes
234 egional cardiac denervation (CD), myocardial stunning was intensified, ie, at 12 hours reperfusion wa
236 rts subjected to 20-minute ischemia in which stunning was mitigated by 10-minute reperfusion with low
237 during dobutamine stress, and (3) myocardial stunning was observed during postdobutamine recovery.
239 easure of the overall severity of myocardial stunning) was reduced by 68% (control, 129 +/- 16 arbitr
240 mental stress echocardiography parameters of stunning were attenuated in patients while taking amlodi
241 The protective effects of IB-MECA against stunning were completely blocked by pretreatment with th
244 denosine blocker 8-PT enhanced the degree of stunning when given before ischemia but did not induce a
245 n = 10) abrogated the late PC effect against stunning, whereas a 10-fold lower dose (0.5 mg/kg; group
246 rfusion followed by ventricular dysfunction (stunning), which more closely resembles clinical conditi
248 eatment to assess the degree of postexercise stunning with simultaneous sestamibi single-photon emiss
250 th substantial protection against myocardial stunning without the need for concomitant administration
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。